Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 01, 2024

Impact of HER2-Low Status in Patients With Early-Stage Breast Cancer and Non–Pathological Complete Response After Neoadjuvant Chemotherapy

Breast Cancer Research and Treatment


Additional Info

Breast Cancer Research and Treatment
Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
Breast Cancer Res Treat 2023 Dec 08;[EPub Ahead of Print], H Li, JK Plichta, K Li, Y Jin, SM Thomas, F Ma, L Tang, Q Wei, YW He, Q Chen, Y Guo, Y Liu, J Zhang, S Luo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading